Prenetics Global (NASDAQ:PRE – Get Free Report) and Beauty Health (NASDAQ:SKIN – Get Free Report) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.
Insider and Institutional Ownership
25.0% of Prenetics Global shares are held by institutional investors. Comparatively, 93.3% of Beauty Health shares are held by institutional investors. 40.3% of Beauty Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Analyst Recommendations
This is a summary of current recommendations and price targets for Prenetics Global and Beauty Health, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Prenetics Global | 1 | 0 | 4 | 0 | 2.60 |
| Beauty Health | 1 | 5 | 1 | 0 | 2.00 |
Profitability
This table compares Prenetics Global and Beauty Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Prenetics Global | -62.45% | -20.33% | -15.42% |
| Beauty Health | -9.79% | -47.83% | -5.79% |
Volatility & Risk
Prenetics Global has a beta of 0.26, suggesting that its stock price is 74% less volatile than the S&P 500. Comparatively, Beauty Health has a beta of 1.07, suggesting that its stock price is 7% more volatile than the S&P 500.
Earnings and Valuation
This table compares Prenetics Global and Beauty Health”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Prenetics Global | $92.39 million | 3.47 | -$37.71 million | ($4.58) | -4.15 |
| Beauty Health | $300.80 million | 0.30 | -$9.52 million | ($0.22) | -3.18 |
Beauty Health has higher revenue and earnings than Prenetics Global. Prenetics Global is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.
Summary
Beauty Health beats Prenetics Global on 10 of the 14 factors compared between the two stocks.
About Prenetics Global
Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.
About Beauty Health
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Receive News & Ratings for Prenetics Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prenetics Global and related companies with MarketBeat.com's FREE daily email newsletter.
